Trials / Completed
CompletedNCT03717714
Polycan in Combination With Glucosamine for Treatment of Knee Osteoarthritis
A Randomized, Double-blind, Active Controlled, 12-week Follow-up, Pilot Study to Evaluate the Safety and Efficacy of Polycan in Combination With Glucosamine for Treatment of Knee Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Vietstar Biomedical Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study is to examine the Safety and Efficacy of black yeast beta-glucan produced from Aureobusidium pulluluns SM-2001 (Polycan), in combination with glucosamine in reducing knee osteoarthritis (OA) associated symptoms. This study is a double-blind, randomized, active-controlled trial conducted with 100 OA patients, aged 35-80 years using a formulated product
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Glucosamine 1500 mg | Patients in this group take 3 capsules, each capsule contains Placebo 16.7mg and Glucosamine 500 mg, once a day for 12 weeks |
| DIETARY_SUPPLEMENT | Polycan 50mg + Glucosamine 750 mg | Patients in this group take 3 capsules, each capsule contains Polycan 16.7mg and Glucosamine 250 mg, once a day for 12 weeks |
| DIETARY_SUPPLEMENT | Polycan 50mg + Glucosamine 1500 mg | Patients in this group take 3 capsules, each capsule contains Polycan 16.7mg and Glucosamine 500 mg, once a day for 12 weeks |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2018-05-30
- Completion
- 2018-05-30
- First posted
- 2018-10-24
- Last updated
- 2018-10-24
Locations
1 site across 1 country: Vietnam
Source: ClinicalTrials.gov record NCT03717714. Inclusion in this directory is not an endorsement.